Hyman Phelps and McNamara
 
Paul M. Hyman
Director
Photo of Paul M. Hyman

(202) 737-4281
phyman@hpm.com
Download Vcard

Practice Areas
Foods and Dietary Supplements
Corporate Transactions
Enforcement
Consumer Products

Education
LL.B., Yale Law School, 1965
B.A., History, University of Chicago, 1961

Bar Admissions
District of Columbia
United States Supreme Court

Printer Friendly Page

Paul M. Hyman is a founding member of Hyman, Phelps & McNamara. Since opening the firm in 1980, he has led efforts to make it the premiere FDA law practice. He brings almost five decades of perspective to the regulatory priorities and policies of FDA and FTC. Mr. Hyman has advised clients on nearly every aspect of FDA regulation, ranging from premarket approvals, to labeling and post-market compliance, and has defended against enforcement actions such as warning letters, recalls, and court actions. He has wide-ranging experience interpreting FTC regulation of advertising and promotion.

Mr. Hyman has advised clients from pharmaceutical, medical device, OTC drug, cosmetic, food, and dietary supplement companies. His understanding of the federal and state regulatory landscape helps clients meet their business objectives while managing risk. In recent years, Mr. Hyman has focused on regulatory issues surrounding OTC drugs, cosmetics, food, medical foods, and dietary supplements.

Throughout his career, Mr. Hyman has held several leadership positions in industry organizations and on advisory boards. He chaired the Federal Bar Association's Food and Drug Law Committee from 1972 to 1974. Mr. Hyman was a member of the Board of Directors of the American Council on Science and Health from 1987 to 1989, and a member of the Editorial Advisory Board of the Food and Drug Law Journal from 1995 to 1997. He was counsel to the Regulatory Affairs Certification Board from 1993 until 2002.

Mr. Hyman began his career as a trial attorney in the Chief Counsel's Office of FDA (then the HEW Office of General Counsel, Food and Drug Division). He later entered private practice in Washington, D.C., ultimately co-founding Hyman, Phelps & McNamara in 1980.


Related Experience
OTC Drugs and Cosmetics
• Assists with regulatory strategies for manufacturers.
• Counsels clients on OTC monograph and related rulings and interpretations.
• Advises on labeling and advertising materials.

Foods and Dietary Supplements
• Helps clients develop regulatory and business strategies.
• Provides guidance on FSMA and FDA's interpretation and implementation of its requirements.

Enforcement
• Provides counsel on recalls and inspections.
• Assists with responses to warning letters and FDA Form 483's.
• Defend challenges from FDA, FTC, NAD and other regulatory bodies.

Awards & Recognition
• ALM Legal Leaders, 2014
• The International Who's Who Legal Directory, Life Sciences, Regulatory Section, 2013 - 2016
• DC Super Lawyer, 2007 through 2011
• FDLI Distinguished Service and Leadership Award, 2003
• Special Recognition Award, the Regulatory Affairs Professional Society, 1999

Professional Affiliations
American Bar Association
District of Columbia Bar
Federal Bar Association
Food and Drug Law Institute

Articles / Publications    -    see more articles
•  The Cost of Inadequate Substantiation,  November 5, 2010

•  Contracting with the Dietary Supplement cGMPs in Mind,  September 2009

•  Dermatologic Therapy,  May 9, 2009

•  Claims for Functional Foods Under the Current Food Regulatory Scheme,  October/November 2002

•  U.S. Food and Drug Law and FDA - A Historical Background,  July 2002


Speaking Engagements    -    see more speaking engagements
•  Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care Products, OTC Drugs Versus Cosmetics: Understanding the Differences, Examining the Subtleties, and Clarifying the Rules to Promote Product Innovation, March 6-8, 2017
•  Legal, Regulatory and Compliance Forum on Cosmetics & Personal Care Products, Is it a Cosmetic, A Drug, Or Something Else: Exploring Regulatory Lines for ‘Cosmetic-Type’ Products Which Affect the Structure or Function of the Body, March 7-9, 2016
•  XVI International ABPVS Regulatory Forum, 9/14 "An Overview of FDA Warning Letters Model" and 9/15 Member of Food Panel, September 14-15, 2015
•  Legal, Regulatory and Compliance Forum, PMH Co-Speaker: “Drawing the Line Between Cosmetic and Drug Claims Preventing Your Cosmetic From Becoming an Unapproved Drug, March 2-3, 2015
•  Annual Legal, Regulatory and Compliance Forum on Cosmetics, Paul Hyman will serve as a panel member for the Annual Legal, Regulatory and Compliance Forum on Cosmetics, January 27-28, 2015